Patients Discontinuing Slimming Injections Gain Back Pounds Four Times Faster Than Dieters

Fresh analysis reveals that people who come off popular GLP-1 drugs like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who halt traditional lifestyle plans.

Research printed in a prominent medical journal shows that while obese individuals can lose a large proportion of their body weight while on the medication, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"People buying these treatments need to be cognizant of the risk of rapid weight regain when the therapy is stopped," stated lead investigator Dr. Susan Jebb.

That rate of recovery suggests a reversion to starting mass within about 18 months.

Weighing Therapies

The analysis, which reviewed dozens of studies involving thousands of participants, compared the effects of GLP-1 agonists with older methods.

The team note that individuals who shed pounds through dieting typically have a slower creep back—approximately 0.1 kg a month—once they finish.

Explaining the Quick Rebound

Doctors believe the way of the injections explains the accelerated weight return.

GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Sustained high doses of the hormone levels far above than normal may cause the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this medication results in hunger is no longer kept in check, making binge eating much more probable."

An Ongoing Issue?

Health authorities suggest the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.

Professionals contend that, considering the high risk of weight regain, the therapy might need to be long-term.

This view is echoed by drug manufacturers, who say that the results "emphasize the long-term nature of excess weight," comparing it to managing diseases like high blood pressure.

Patient Experiences

People who have come off the jabs explain a sudden resurgence of cravings.

"I experienced a switch activating and I was suddenly extremely hungry," recalled a patient.

This challenge is worsened if users have not developed permanent dietary or behavioural modifications during treatment.

Widespread Use

Recent estimates indicate that millions of adults in the UK have used these injections in the past year, with demand remaining high.

• Adoption is more common among females than men.
• The 40s and 50s age group shows the greatest usage rates.
• Many access the medications through private healthcare rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are effective tools for weight loss, they are not a magic cure and lasting health benefits likely depends on combined lifestyle support.